Harvard Bioscience Inc - ESG Rating & Company Profile powered by AI
This page contains a zero-cost Sustainability assessment covering Harvard Bioscience Inc. Alternative corporations in the scoring industry group for Harvard Bioscience Inc are shown. The assessment of Harvard Bioscience Inc leverages intelligence from across the web as well as from public documents by Harvard Bioscience Inc.
Harvard Bioscience Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.0; made up of an environmental score of 0.0, social score of 1.3 and governance score of 4.8.
2.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1571 | Venus Remedies Ltd | 2.1 | Medium |
1571 | Xphyto Therapeutics Corp | 2.1 | Medium |
1608 | Harvard Bioscience Inc | 2.0 | Medium |
1608 | Ahlcon Parenterals (India) Ltd | 2.0 | Medium |
1608 | Hansoh Pharmaceutical Group Company Ltd | 2.0 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Harvard Bioscience Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Harvard Bioscience Inc report the average age of the workforce?
Sign up for free to unlockDoes Harvard Bioscience Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Harvard Bioscience Inc offer flexible work?
Sign up for free to unlockDoes Harvard Bioscience Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Harvard Bioscience Inc conduct supply chain audits?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Harvard Bioscience Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose water use targets?
Sign up for free to unlockDoes Harvard Bioscience Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Harvard Bioscience Inc have a product recall in the last two years?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Harvard Bioscience Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Harvard Bioscience Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose parental leave metrics?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Harvard Bioscience Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Harvard Bioscience Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Harvard Bioscience Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose its waste policy?
Sign up for free to unlockDoes Harvard Bioscience Inc report according to TCFD requirements?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose energy use targets?
Sign up for free to unlockDoes Harvard Bioscience Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Harvard Bioscience Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Harvard Bioscience Inc
These potential risks are based on the size, segment and geographies of the company.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.